Biogen Inc.

NAS: BIIB

GO
/marketstate/country/us

Before the Bell

/zigman2/quotes/201531540/composite

$

268.99

Change

+1.99 +0.75%

Volume

Volume 94,956

Oct 3, 2022, 8:13 a.m.

Real time quotes

/zigman2/quotes/201531540/composite

Previous close

$ 267.00

$ 267.00

Change

+2.72 +1.03%

Day low

Day high

$257.02

$271.49

Open
Open: 265.51

52 week low

52 week high

$187.16

$290.76

Open

Market cap

$38.75B

Average volume

1.33M

P/E ratio

19.06

Rev. per Employee

$1.04M

EPS

14.01

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/biib

MarketWatch News on BIIB

  1. The 5 Best—and 5 Worst—Stocks in the Nasdaq This Quarter

    4:42 p.m. Sept. 30, 2022

    - Angela Palumbo

  2. The 5 Best—and 5 Worst—Stocks in the S&P 500 This Quarter

    4:34 p.m. Sept. 30, 2022

    - Karishma Vanjani

  3. Biogen stock price target raised to $275 from $221 at J.P. Morgan

    6:13 a.m. Sept. 30, 2022

    - Tomi Kilgore

  4. Biogen stock price target raised to $300 from $230 at Oppenheimer

    8:40 a.m. Sept. 29, 2022

    - Tomi Kilgore

  5. New Alzheimer's Drug Success Was a Shock. Now There Are 5 Big Questions.

    11:17 a.m. Sept. 28, 2022

    - Josh Nathan-Kazis

  6. Biogen upgraded to outperform at BMO Capital

    10:10 a.m. Sept. 28, 2022

    - Tomi Kilgore

  7. Biogen stock price target raised to $217 from $183 at Wedbush

    7:11 a.m. Sept. 28, 2022

    - Tomi Kilgore

  8. Biogen's stock rockets 43.1% premarket after positive Alzheimer's drug trial

    5:59 a.m. Sept. 28, 2022

    - Tomi Kilgore

  9. Alzheimer's Drug Slowed Cognitive Decline in Trial

    8:04 p.m. Sept. 27, 2022

    - Liz Moyer

  10. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/biib

Other News on BIIB

  1. When Should You Sell A Stock?

    8:45 a.m. Oct. 1, 2022

    - Seeking Alpha

  2. Wall Street Breakfast: What Moved Markets

    7:33 a.m. Oct. 1, 2022

    - Seeking Alpha

  3. Nike, Biogen, CarMax: Stocks That Defined the Week

    6:28 p.m. Sept. 30, 2022

    - Francesca Fontana

  4. Amylyx Prices Newly Approved ALS Drug at $12,500 a Month

    4:03 p.m. Sept. 30, 2022

    - Joseph Walker

  5. LLY & PRTA in Spotlight on BIIB-Eisai's AD Drug Data

    9:39 a.m. Sept. 29, 2022

    - Zacks.com

  6. Stock Market News for Sep 29, 2022

    9:10 a.m. Sept. 29, 2022

    - Zacks.com

  7. Biden’s Alzheimer’s Lapse

    6:45 p.m. Sept. 28, 2022

    - The Editorial Board

  8. Why did Biogen stock surge today? Alzheimer's drug data

    4:59 p.m. Sept. 28, 2022

    - Seeking Alpha

  9. Stocks Soar as Bond Prices Rally

    4:37 p.m. Sept. 28, 2022

    - Anna Hirtenstein

  10. A Positive Amyloid Trial, Finally?

    4:11 p.m. Sept. 28, 2022

    - Seeking Alpha

  11. Biogen's Lecanemab Data Blows Alzheimer's Race Open Again

    4:08 p.m. Sept. 28, 2022

    - Seeking Alpha

  12. Acumen Pharma at 11-month high on rivals’ Alzheimer’s data

    3:43 p.m. Sept. 28, 2022

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/biib

Press Releases on BIIB

  1. Nasdaq 100 Movers: AAPL, BIIB

    10:45 a.m. Sept. 28, 2022

    - MarketNewsVideo.com

  2. S&P 500 Movers: AAPL, BIIB

    10:45 a.m. Sept. 28, 2022

    - MarketNewsVideo.com

  3. Biogen Inc. Common Stock BIIB Investment Analysis

    7:28 a.m. Sept. 23, 2022

    - Stock Traders Daily

  4. Biogen Inc. Common Stock BIIB Investment Report

    3:34 p.m. Sept. 13, 2022

    - Stock Traders Daily

  5. Best Stocks To Buy Now? 4 Biotech Stocks In Focus

    12:10 p.m. Sept. 11, 2022

    - StockMarket.com

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.